Current Advances in the Management of Nonurothelial Subtypes of Bladder Cancer
Urothelial cancer (UC) is the most common histology seen in bladder tumors. The 2022
WHO classification of urinary tract tumors includes a list of less common subtypes (formerly …
WHO classification of urinary tract tumors includes a list of less common subtypes (formerly …
Bladder cancer variants—one disease with many faces
B Czerniak - Nature Reviews Urology, 2024 - nature.com
Bladder cancer progression to microscopically distinct variants such as sarcomatoid, small
cell, micropapillary and plasmacytoid is associated with more aggressive clinical behaviour …
cell, micropapillary and plasmacytoid is associated with more aggressive clinical behaviour …
Integrated immuno-transcriptomic analysis of ovarian cancer identifies a four-chemokine-dominated subtype with antitumor immune-active phenotype and favorable …
Background Ovarian cancer (OV) is a heterogeneous disease but has traditionally been
treated as an immunologically cold malignancy. The relationship between the immune …
treated as an immunologically cold malignancy. The relationship between the immune …
Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma with Prognostic Implications
Small cell carcinomas (SMC) of the lung are now molecularly classified based on the
expression of transcriptional regulators (NEUROD1, ASCL1, POU2F3, and YAP1) and …
expression of transcriptional regulators (NEUROD1, ASCL1, POU2F3, and YAP1) and …
Plasmacytoid urothelial carcinoma of the urinary bladder–A clinicopathological and molecular analysis of 52 cases
L Zheng, H Chen, J Zhao, S Roy-Chowdhuri… - Human Pathology, 2024 - Elsevier
Plasmacytoid urothelial carcinoma (UC) is a rare histologic subtype of bladder cancer that is
associated with an aggressive clinical behavior. We analyzed the clinicopathologic and …
associated with an aggressive clinical behavior. We analyzed the clinicopathologic and …
[HTML][HTML] Integrated bioinformatics investigation of adenylyl cyclase family co-expression network in bladder cancer followed by preliminary validation of member 2 …
H Wang, W Luo, J Ji, M Qu, S Jiang… - Translational Cancer …, 2024 - ncbi.nlm.nih.gov
Background The adenylyl cyclase (ADCY) gene family encodes enzymes responsible for the
synthesis of cyclic adenosine monophosphate (cAMP) from adenosine triphosphate (ATP) …
synthesis of cyclic adenosine monophosphate (cAMP) from adenosine triphosphate (ATP) …
Histologic variants in bladder cancer harbor aggressive molecular features including TM4SF1 expression and a CA125+ cell state
H Yang, H Song, E Yip, K Chang, P Allegakoen, KL Lu… - bioRxiv, 2024 - biorxiv.org
Histologic variant (HV) subtypes of bladder cancer are clinically aggressive tumors that are
more resistant to standard therapy compared to conventional urothelial carcinoma (UC) …
more resistant to standard therapy compared to conventional urothelial carcinoma (UC) …